About 1 result found for searched term "875337-44-3" (0.128 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1922 | MGCD265 | c-Met |
| MGCD265 is a novel multitargeted receptor tyrosine kinase (RTK) inhibitor that targets the mesenchymal epithelial transition (c-Met) and the vascular endothelial growth factor (VEGF) receptors (VEGFR1, VEGFR2, and VEGFR3). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
